August 2022: TempTraq by Blue Spark Technologies Inc

Early fever detection leads to better patient care.

Image credit: PR Newswire

Blue Spark Technologies Inc produces TempTraq, an FDA Cleared Class II medical device that gives Healthcare providers the first wireless continuous temperature monitor in the form of a soft, comfortable, disposable patch. TempTraq can significantly improve the way temperature is measured in the clinical environment and provides clinicians with a quicker, easier, and more effective way to measure temperature.

Accuracy and equivalency in three hospital studies:
  • Cleveland Clinic
  • University Hospitals Seidman Cancer Center
  • Cincinnati Children’s Hospital

 

In a clinical study conducted by University Hospitals Seidman Cancer Center, TempTraq was shown to detect temperature rises earlier than the standard of care by a median of 140.1 minutes (range of 30-180 minutes) with bone marrow transplant patients.

WT thinks this is what earns TempTraq the title “Innovation of the Month”.

Jürgen Thalmayer
August 1, 2022

August 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Graphene-Based Sensors Detect Diabetic Foot Ulcers Before They Cause Injury

Bonbouton began tackling the problem of undetected diabetic foot issues.

NUS Scientists Develop Electronic Skin with Exceptional Sense of Touch for Prosthetics

Scientists have been working hard to improve prosthetic technology.

Wearables Can Detect COVID-19 and Even Signs of Depression, Fitbit CEO Tells Axios

When Fitbit was founded in 2007, the company’s focus was to create small wearable devices that...

Fighting Against NCDs - Wearables for Chronic Disease Management and Mobility Challenges

Noncommunicable diseases (NCDs) constitute one of the major public health challenges for development
Discover more